156 related articles for article (PubMed ID: 32440143)
1. Targeting eIF3f Suppresses the Growth of Prostate Cancer Cells by Inhibiting Akt Signaling.
Li J; Yu W; Ge J; Zhang J; Wang Y; Wang P; Shi G
Onco Targets Ther; 2020; 13():3739-3750. PubMed ID: 32440143
[TBL] [Abstract][Full Text] [Related]
2. Decreased expression of eukaryotic initiation factor 3f deregulates translation and apoptosis in tumor cells.
Shi J; Kahle A; Hershey JW; Honchak BM; Warneke JA; Leong SP; Nelson MA
Oncogene; 2006 Aug; 25(35):4923-36. PubMed ID: 16532022
[TBL] [Abstract][Full Text] [Related]
3. Phosphorylation of the eukaryotic initiation factor 3f by cyclin-dependent kinase 11 during apoptosis.
Shi J; Hershey JW; Nelson MA
FEBS Lett; 2009 Mar; 583(6):971-7. PubMed ID: 19245811
[TBL] [Abstract][Full Text] [Related]
4. Estrogen receptor α promotes protein synthesis by fine-tuning the expression of the eukaryotic translation initiation factor 3 subunit f (eIF3f).
Cuesta R; Berman AY; Alayev A; Holz MK
J Biol Chem; 2019 Feb; 294(7):2267-2278. PubMed ID: 30573685
[TBL] [Abstract][Full Text] [Related]
5. The translation initiation factor 3f (eIF3f) exhibits a deubiquitinase activity regulating Notch activation.
Moretti J; Chastagner P; Gastaldello S; Heuss SF; Dirac AM; Bernards R; Masucci MG; Israël A; Brou C
PLoS Biol; 2010 Nov; 8(11):e1000545. PubMed ID: 21124883
[TBL] [Abstract][Full Text] [Related]
6. Loss of the eukaryotic initiation factor 3f in pancreatic cancer.
Doldan A; Chandramouli A; Shanas R; Bhattacharyya A; Cunningham JT; Nelson MA; Shi J
Mol Carcinog; 2008 Mar; 47(3):235-44. PubMed ID: 17918192
[TBL] [Abstract][Full Text] [Related]
7. eIF3f reduces tumor growth by directly interrupting clusterin with anti-apoptotic property in cancer cells.
Lee JY; Kim HJ; Rho SB; Lee SH
Oncotarget; 2016 Apr; 7(14):18541-57. PubMed ID: 26988917
[TBL] [Abstract][Full Text] [Related]
8. CAV3.1 knockdown suppresses cell proliferation, migration and invasion of prostate cancer cells by inhibiting AKT.
Hu S; Li L; Huang W; Liu J; Lan G; Yu S; Peng L; Xie X; Yang L; Nian Y; Wang Y
Cancer Manag Res; 2018; 10():4603-4614. PubMed ID: 30410396
[TBL] [Abstract][Full Text] [Related]
9. Loss of the eukaryotic initiation factor 3f in melanoma.
Doldan A; Chandramouli A; Shanas R; Bhattacharyya A; Leong SP; Nelson MA; Shi J
Mol Carcinog; 2008 Oct; 47(10):806-13. PubMed ID: 18381585
[TBL] [Abstract][Full Text] [Related]
10. MIIP inhibits the growth of prostate cancer via interaction with PP1α and negative modulation of AKT signaling.
Yan G; Ru Y; Yan F; Xiong X; Hu W; Pan T; Sun J; Zhang C; Wang Q; Li X
Cell Commun Signal; 2019 May; 17(1):44. PubMed ID: 31092266
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of miR-133a-3p promotes prostate cancer bone metastasis via activating PI3K/AKT signaling.
Tang Y; Pan J; Huang S; Peng X; Zou X; Luo Y; Ren D; Zhang X; Li R; He P; Wa Q
J Exp Clin Cancer Res; 2018 Jul; 37(1):160. PubMed ID: 30021600
[TBL] [Abstract][Full Text] [Related]
12. eIF3f: a central regulator of the antagonism atrophy/hypertrophy in skeletal muscle.
Sanchez AM; Csibi A; Raibon A; Docquier A; Lagirand-Cantaloube J; Leibovitch MP; Leibovitch SA; Bernardi H
Int J Biochem Cell Biol; 2013 Oct; 45(10):2158-62. PubMed ID: 23769948
[TBL] [Abstract][Full Text] [Related]
13. YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer.
Li J; Xie H; Ying Y; Chen H; Yan H; He L; Xu M; Xu X; Liang Z; Liu B; Wang X; Zheng X; Xie L
Mol Cancer; 2020 Oct; 19(1):152. PubMed ID: 33121495
[TBL] [Abstract][Full Text] [Related]
14. Knockdown of RPL34 suppresses osteosarcoma cell proliferation likely through EIF3/FAU signaling pathway.
Huang P; Zhao J; Fowdur M; Liu Y; Wu H; He M
Transl Cancer Res; 2019 Jun; 8(3):848-855. PubMed ID: 35116824
[TBL] [Abstract][Full Text] [Related]
15. The tumor suppressive role of eIF3f and its function in translation inhibition and rRNA degradation.
Wen F; Zhou R; Shen A; Choi A; Uribe D; Shi J
PLoS One; 2012; 7(3):e34194. PubMed ID: 22457825
[TBL] [Abstract][Full Text] [Related]
16.
Xiao ZM; Lv DJ; Yu YZ; Wang C; Xie T; Wang T; Song XL; Zhao SC
Front Cell Dev Biol; 2021; 9():678967. PubMed ID: 34249931
[TBL] [Abstract][Full Text] [Related]
17. KLF16 Affects the MYC Signature and Tumor Growth in Prostate Cancer.
Zhang J; Yu W; Wang X; Hu B; Wu D; Shi G
Onco Targets Ther; 2020; 13():1303-1310. PubMed ID: 32103997
[TBL] [Abstract][Full Text] [Related]
18. Targeting POH1 inhibits prostate cancer cell growth and enhances the suppressive efficacy of androgen deprivation and docetaxel.
Yu W; Li J; Wang Q; Wang B; Zhang L; Liu Y; Tang M; Xu G; Yang Z; Wang X; Zhang J; Liu Y; Shi G
Prostate; 2019 Aug; 79(11):1304-1315. PubMed ID: 31212367
[TBL] [Abstract][Full Text] [Related]
19. eIF3f depletion impedes mouse embryonic development, reduces adult skeletal muscle mass and amplifies muscle loss during disuse.
Docquier A; Pavlin L; Raibon A; Bertrand-Gaday C; Sar C; Leibovitch S; Candau R; Bernardi H
J Physiol; 2019 Jun; 597(12):3107-3131. PubMed ID: 31026345
[TBL] [Abstract][Full Text] [Related]
20. eIF3f Mediates SGOC Pathway Reprogramming by Enhancing Deubiquitinating Activity in Colorectal Cancer.
Pan Q; Yu F; Jin H; Zhang P; Huang X; Peng J; Xie X; Li X; Ma N; Wei Y; Wen W; Zhang J; Zhang B; Yu H; Xiao Y; Liu RY; Liu Q; Meng X; Lee MH
Adv Sci (Weinh); 2023 Sep; 10(27):e2300759. PubMed ID: 37544925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
